News Focus
News Focus
Followers 65
Posts 10174
Boards Moderated 0
Alias Born 03/29/2015

Re: biosectinvestor post# 427307

Thursday, 12/16/2021 10:21:11 PM

Thursday, December 16, 2021 10:21:11 PM

Post# of 819542
The benefit of sticking with original trial design is that DCVax-L would have been available years earlier which is good for long term investors and patients alike.

Instead we just get delay piled on delay and the patient body count rises.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News